LONZA GROUP AG :Lonza And Vertex Sign A Long-Term Commercial Supply Agreement For Casgevy® (Exagamglogene Autotemcel).Lonza Group Ag - To Manufacture World'S First Crispr/Cas9 Cell Therapy.Lonza Group Ag - Geleen (Nl) Site Is Now Approved By Fda, Ema And Mhra For Commercial Production Of Casgevy^®.Lonza Group Ag - Casgevy To Be Manufactured At Lonza'S Geleen Facility.Lonza Group Ag - Geleen Site Approved By Fda, Ema, Mhra For Casgevy Production.Lonza Group Ag - Portsmouth Site Expected To Begin Gmp Operations In 2025.
免責聲明：投資有風險，本文並非投資建議，以上內容不應被視為任何金融產品的購買或出售要約、建議或邀請，作者或其他用戶的任何相關討論、評論或帖子也不應被視為此類內容。本文僅供一般參考，不考慮您的個人投資目標、財務狀況或需求。TTM對信息的準確性和完整性不承擔任何責任或保證，投資者應自行研究並在投資前尋求專業建議。